CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 243 enrolled
Drug / intervention
Zilver Vena Venous Self-Expanding Stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01970007
NCT01970007N/ACompleted
CompareCT.gov

Evaluation of the Zilver® Vena™ Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction

Cook Research Incorporated·interventional·Posted Oct 25, 2013·Updated Apr 8, 2021

In Brief

A clinical study evaluating Zilver Vena Venous Self-Expanding Stent for Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein. Completed, enrolled 243 participants across 30 sites in 2 countries.

Detailed Summary

The purpose of the VIVO Clinical Study is to evaluate the safety and effectiveness of the Zilver® Vena™ Venous Stent in the treatment of symptomatic iliofemoral venous outflow obstruction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSymptomatic Venous Outflow Obstruction in the Iliofemoral Vein
CountriesTaiwan, United States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 25, 2013
Enrollment StartDec 13, 2013
Primary CompletionNov 20, 2017
Study CompletionNov 20, 2019
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 12.7 years ago

Interventions

Zilver Vena Venous Self-Expanding Stentdevice

stenting